Skip to content

APOTHEEK ACANTHUS

Active
Public limited companyfounded 1989active for 36 yearsYzerhand(BEV) 19, 9120 Beveren-Kruibeke-Zwijndrecht, BelgiumKBO/BCE: BE 0439.147.209

From the official registers: KBO 36 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK ACANTHUS has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €807,642 and a net result of €100,774. Equity has been growing by about 25% per year since 2018. Its solvency ranks better than 91% of 5,036 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 01-12-1989 Normal situation
Legal form
Public limited company
Registered office
Yzerhand(BEV) 19, 9120 Beveren-Kruibeke-Zwijndrecht
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.046.514.809 9120 Beveren-Kruibeke-Zwijndrecht, since 09-01-1990
Financial year end
31 December
Peppol
Reachable since 18-11-2025

Board and ownership

Board
  • De Vriendt MartineDirector · since 01-10-2017
  • Van Nuffel TomDirector · since 01-10-2017

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€281,144
▼ 0.2%
Turnover
≈ €1.0m
estimated
Profit
€100,774
▼ 1.1%
Equity
€807,642
▲ 14.3%
Total assets
€960,487
▲ 10.0%
Staff
2.4 FTE
=
2025 accounts filed 21 days before the deadline
Filed on 10-07-2026at the National Bank
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskFounded in 1989Equity €807,642 (84.1% of total assets)Size: 2.4 FTE, total assets €960,487Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 73% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 84.1% of total assets
Liquidity 55-1
short-term debt 15.9% · cash 6.9%
Profitability 82-1
return on assets 10.5%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025highest value 09-2025: 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026lowest value 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €75,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.19 (5.69 in 2024), above the usual 1.5. Short-term debt is 15.9% and cash 6.9% of total assets. 15.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 60% on liquidity, 74% on profitability and 67% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 1989
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €807,642 (84.1% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Size: 2.4 FTE, total assets €960,487
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-07-2026, 21 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
21 days early
2024
21 days late
2023
2 days early
2022
29 days late
2021
31 days late
2020
23 days late
2019
91 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 25 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 21 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 91% of companies in retail tradesector median 36.1% · 5,036 companies 84.1% View
  • Positive: 8 profitable years in a rowprofit 2025: €100,774 8 years View

Documents

Annual accounts at the NBB

All 36 annual accounts

Articles and registers

Key facts about APOTHEEK ACANTHUS

What is the company number of APOTHEEK ACANTHUS?
The company number of APOTHEEK ACANTHUS is 0439.147.209. The VAT number is the same number with BE in front: BE 0439.147.209.
Where is APOTHEEK ACANTHUS based?
The registered office is at Yzerhand(BEV) 19, 9120 Beveren-Kruibeke-Zwijndrecht.Company details
What does APOTHEEK ACANTHUS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK ACANTHUS?
The legal form of APOTHEEK ACANTHUS is Public limited company (NV).
When was APOTHEEK ACANTHUS founded?
APOTHEEK ACANTHUS was founded on 01-12-1989.
Is APOTHEEK ACANTHUS still active?
Yes, APOTHEEK ACANTHUS is an active enterprise in the KBO register.
How many employees does APOTHEEK ACANTHUS have?
APOTHEEK ACANTHUS had an average of 2.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK ACANTHUS?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €281,144 and 47 comparable companies (NACE 477). It probably lies between €790,000 and €1.7m.
Is APOTHEEK ACANTHUS profitable?
In financial year 2025, APOTHEEK ACANTHUS made a profit of €100,774.
Where can I find the annual accounts of APOTHEEK ACANTHUS?
APOTHEEK ACANTHUS filed 36 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of APOTHEEK ACANTHUS due?
APOTHEEK ACANTHUS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as APOTHEEK ACANTHUS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €876,000 and €1.2m, founded between 1988 and 1991.

CompanyTotal assetsGross margin
APOTHEEK ACANTHUS Beveren-Kruibeke-Zwijndrecht€1.0m€0.3m
FARMACON Lokeren€0.9m€0.3m
APOTHEEK PALMANS Lanaken€1.0m€0.3m
PHARMACIE RAMLOT Meix-devant-Virton€1.0m€0.3m
APOTHEEK PAMELSE KLEI Roosdaal€0.9m€0.2m
HERTECANT FARMA Berlare€1.2m€0.3m
APOTHEEK RUELENS Beveren-Kruibeke-Zwijndrecht€0.9m€0.4m
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.